课题基金 / 基金详情

SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck Cancer

SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck Cancer
SCH:头部适应性放射治疗的个性化重新安排
批准号:
10737816
负责人:
Clifton David Fuller
金额:
$8.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-01 至 2025-04-30
关键词:
AddressAdoptionAffectAgingAlgorithmsAnatomyAreaBehaviorCancer ControlCapitalClinicalClinical DataClinical TreatmentCommunitiesCommunity HospitalsComplicationComputer softwareCoupledDataData SetDecision MakingDecision Support SystemsDevelopmentDevicesDiagnosisDoseEconomicsEmerging TechnologiesEnvironmentEquipmentEvaluationEvolutionGoalsHead CancerHead and Neck CancerHead and neck structureHealthHealth PolicyHealth TechnologyHealthcareHumanHuman ResourcesImageIncentivesIndividualInstructionInsurance CarriersInterventionLifeLinear Accelerator Radiotherapy SystemsMagnetic Resonance ImagingMalignant NeoplasmsMalignant neoplasm of larynxMalignant neoplasm of pharynxMedical DeviceMedicareMethodologyMethodsModelingModernizationMonitorMorbidity - disease rateNeck CancerNormal tissue morphologyOperations ResearchOrganOutcomeOverdosePatient CarePatient imagingPatientsPhysiciansPoliciesProbabilityProcessPropertyProviderRadiationRadiation therapyRegimenResearchResourcesRiskSMART healthScheduleScienceSelf-Help DevicesSeriesSoftware ToolsStructureSurvivorsSystemSystems IntegrationTechniquesTechnologyTimeToxic effectTumor VolumeUncertain RiskUncertaintyValidationVariantWorkadvanced analyticsbasecancer radiation therapychemoradiationclinical implementationconnected healthcostdesignevidence basehead and neck cancer patientimage guided radiation therapyimprovedin silicoindividual patientindividualized medicineinnovationinsightlow and middle-income countriesmalignant mouth neoplasmmodels and simulationmultidisciplinarynew technologynext generationnovelprogramsprototyperadiation-induced injuryresponserisk stratificationside effectsoft tissuestandard caresupport toolstheoriestooltreatment planningtreatment responsetreatment stratificationtumor

项目摘要

项目成果

Clifton David Fuller的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Head and neck cancers (HNCs) account for nearly 3% of all cancers in the U.S. and most commonly affect aging individuals. While chemo-radiotherapy is the standard treatment approach for HNC, the method is known to cause substantial side-effects. In particular, anatomical changes occurring during the treatment may result in under-coverage of the clinical target volume or over-dosage of organs at risk. The project will develop novel optimization models for Adaptive Radiation Therapy (ART) – a customized treatment planning approach for individual patients designed by evaluating the systematic and random variations in tumor response. The models will use imaging data of tumor volume and normal tissue complication probabilities to determine the optimal number and timing of treatment replans. The models will provide personalized optimization through sequential decision-making based on response to treatment, as well as optimization and evaluation of simple threshold replanning policies often used by doctors. Optimal behavior in the face of conflicting payer/provider perspectives for emerging technologies will also be analyzed using mechanism design techniques. ART requires information about patient-state as well as transition probabilities describing the tumor's evolution over time. Since the process inherently calls for sequential decision-making under uncertainty, the proposed optimization models use a Markov Decision Process (MDP). The resulting optimal policies may be difficult to implement in practice, especially in centers lacking state-of-the-art equipment. Therefore, the proposed work will further evaluate simple threshold replanning policies using a bilevel programming framework. In particular, the bilevel program will find threshold values for various patient classes by minimizing the deviation from the MDP-prescribed policy. The proposed framework offers multiple avenues for methodological contributions. The novel MDP design framework is an incredibly powerful tool that can be used to model many interesting questions. We will explore ways of discretizing the continuous state spaces and estimating transition probabilities based on patient imaging data. We will explore algorithms for solving bilevel programs, especially utilizing the structure and properties of the lower-level MDP models. Finally, we will study applications of the principal-agent framework from economics in modeling payer/provider interactions for emerging clinical therapies. RELEVANCE (See instructions): This study uses novel models to develop and validate an integrated approach to reduce cancer radiotherapy side effects while maintaining or improving cancer control. It will maximize efficiency for patients and providers. Its findings will inform decisions about individual radiation planning, optimize risk- stratified treatment, and healthcare policy implementation of effective new technology interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)
Diversity Supplement: SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head and Neck Cancer
  • 批准号:
    10599546
  • 项目类别:
  • 资助金额:
    $6.48万
  • 财政年份:
    2021
  • 负责人:
    Clifton David Fuller
  • 依托单位:
SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck Cancer
  • 批准号:
    10397692
  • 项目类别:
  • 资助金额:
    $24.72万
  • 财政年份:
    2021
  • 负责人:
    Clifton David Fuller
  • 依托单位:
SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck Cancer
  • 批准号:
    10737817
  • 项目类别:
  • 资助金额:
    $8.39万
  • 财政年份:
    2021
  • 负责人:
    Clifton David Fuller
  • 依托单位:
海外基金